Human Papillomavirus Infection and TP53 Gene Mutation in Primary Cervical Carcinoma

References

• Bishop J M. Molecular themes in oncogenesis. Cell 1991; 64: 235–48
   PubMed Web of Science ®Google Scholar
• Weinberg R A. Tumor suppressor genes. Science 1991; 254: 1138–46
   PubMed Web of Science ®Google Scholar
• Crook T, Wrede D, Tidy J A, Mason W P, Evans D J, Vousden K H. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Lancet 1992; 339: 1070–3
   PubMed Web of Science ®Google Scholar
• Fujita M, Inoue M, Tanizawa O, Iwamoto S, Enomoto T. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 1992; 52: 5323–8
   PubMed Web of Science ®Google Scholar
• Borresen A-L, Helland A, Nesland J M, Holm R, Trope C, Kaern J. Papillomaviruses, p53, and cervical cancer. Lancet 1992; 339: 1350–1
   PubMedGoogle Scholar
• Paquette R L, Lee Y Y, Wilczynski S P, et al. Mutations of p53 and human papillomavirus infection in cervical carcinoma. Cancer 1993; 72: 1272–80
   PubMed Web of Science ®Google Scholar
• Helland Å, Holm R, Kristensen G, et al. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas. J Pathol 1993; 171: 105–14
   PubMedGoogle Scholar
• Kessis T D, Slebos R J, Han S M, et al. p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix. Am J Pathol 1993; 143: 1398–405
   PubMed Web of Science ®Google Scholar
• Park D J, Wilczynski S P, Paquette R L, Miller C W, Koeffler H P. p53 mutations in HPV-negative cervical carcinoma. Oncogene 1994; 9: 205–10
   PubMedGoogle Scholar
• Busby-Earle R M C, Steel C M, Williams A R W, Cohen B, Bird C C. p53 mutations in cervical carcinogenesis-low frequency and lack of correlation with human papillomavirus status. Br J Cancer 1994; 69: 732–7
   PubMedGoogle Scholar
• Miwa K, Miyamoto S, Kato H, et al. The role of p53 inactivation in human cervical cell carcinoma development. Br J Cancer 1995; 71: 219–26
   PubMedGoogle Scholar
• Milde-Langosch K, Albrecht K, Joram S, Schlechte H, Giessing M, Loning T. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix and the vulva. Int J Cancer 1995; 63: 639–45
   PubMedGoogle Scholar
• Ikenberg H, Matthay K, Schmitt B, et al. p53 mutation and MDM2 amplification are rare in human papillomavirus-negative cervical carcinomas. Cancer 1995; 76: 57–66
   PubMed Web of Science ®Google Scholar
• Atkin N B, Baker M C. Chromosome 17p loss in carcinoma of the cervix uteri. Cancer Genet Cytogenet 1989; 37: 229–33
   PubMedGoogle Scholar
• Scheffner M, Werness B A, Huibregtse J M, Levine A J, Howley P M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129–36
   PubMed Web of Science ®Google Scholar
• Chiba I, Takahashi T, Nau M M, et al. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene 1990; 5: 1603–10
   PubMed Web of Science ®Google Scholar
• Hollstein M C, Peri L, Mandard A M, et al. Genetic analysis of human esophageal tumors from two high incidence geographic areas: Frequent p53 base substitutions and absence of ras mutations. Cancer Res 1991; 51: 4102–6
   PubMed Web of Science ®Google Scholar
• zur Hausen H. Viruses in human cancer. Science 1991; 254: 1167–73
   PubMed Web of Science ®Google Scholar
• Ferre F, Garduno F. Detection of human papillomavirus types 6/11, 16 and 18 using the polymerase chain reaction. Cancer cells 1989; 7: 215–8
   Google Scholar
• Evander M, Boden E, Bjersing L, Rylander E, Wadell G. Oligonucleotide primers for DNA amplification of the early regions 1, 6, and 7 from human papillomavirus types 6, 11, 16, 18, 31, and 33. Arch Virol 1991; 116: 221–33
   PubMedGoogle Scholar
• Manos M M, Ting Y, Wright D K, Lewis A J, Broker T R, Wolinsky S M. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Molecular Diagnostics of Human Cancer: Cancer Cells, M Furth, M Greave. Cold Spring Harbor Laboratory Press, New York 1989; 7: 209–14
   Google Scholar
• Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989; 86: 2766–70
   PubMed Web of Science ®Google Scholar
• Buchman V L, Chumakov P M, Ninkina N N, Samarina O P, Georgiev G P A. Variation in the structure of the protein-coding regions of the human p53 gene. Gene 1988; 70: 245–52
   PubMed Web of Science ®Google Scholar
• Sanger F, Nicklen S, Coulson A R. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463–7
   PubMed Web of Science ®Google Scholar
• Young L S, Bevan I S, Johnson M A, et al. The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection. Br Med J 1989; 298: 14–8
   PubMed Web of Science ®Google Scholar
• Wilczynski S P, Bergen S, Walker J, Liao S Y, Pearlman L F. Human papillomaviruses and cervical cancer: Analysis of histopathologic features associated with different viral types. Hum Pathol 1988; 19: 697–704
   PubMed Web of Science ®Google Scholar
• Leminen A, Paavonen J, Vesterinen E, Wahlstrom T, Rantala I, Lehtinen M. Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix. Am J Clin Pathol 1991; 95: 647–52
   PubMedGoogle Scholar
• Barnes W, Delgado G, Kurman R J, et al. Possible prognostic significance of human papillomavirus type in cervical cancer. Gynecol Oncol 1988; 29: 267–73
   PubMedGoogle Scholar
• Riou G, Favre M, Jeannel D, Bourhis J, Le Doussal V, Orth G. Association between poor prognosis in early stage invasive carcinomas and non-detection of HPV DNA. Lancet 1990; 335: 1171–4
   PubMed Web of Science ®Google Scholar
• Hollstein M, Sidransky D, Vogelstein B, Harris C C. p53 mutations in human cancers. Science 1991; 253: 49–53
   PubMed Web of Science ®Google Scholar
• Okamoto A, Sameshima Y, Yokoyama S, et al. Frequent allelic losses and mutations of the p53 gene in human ovarian cancer. Cancer Res 1991; 51: 5171–6
   PubMed Web of Science ®Google Scholar
• Yaginuma Y, Westphal H. Analysis of the p53 gene in human uterine carcinoma cell lines. Cancer Res 1991; 51: 6506–9
   PubMedGoogle Scholar
• Oliner J D, Kinzler K W, Meltzer P S, George D L, Vogelstein B. Amplification of a gene coding a p53-associated protein in human sarcomas. Nature 1992; 358: 80–3
   PubMed Web of Science ®Google Scholar